Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  MUMBAI STOCK EXCHANGE  >  Dr. Reddy's Laboratories Limited    500124   INE089A01023

DR. REDDY'S LABORATORIES LIMITED

(500124)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Dr Reddy Laboratories : Half yearly disclosure of related party transactions - Sept 2020

11/20/2020 | 05:41am EST

Dr. Reddy's •·· �;•

Dr. Raddy's Laboratories Ltd.

8-2-337, Road No. 3, Banjara Hills,

Hyderabad - 500 034, Telangana,

India.

CIN: L85195TG1984PLC004507

Tel

:+91 40 4900 2900

Fax

:+91 40 4900 2999

Email :mail@drreddys.com www.drreddys.com

November 19, 2020

Corporate Relationship Department

National Stock Exchange of India Ltd.

BSE Limited

"Exchange Plaza"

Dalal Street, Fort

Bandra-Kurla Complex, Bandra (East),

Mumbai-400 001

Mumbai-400 051

Scrip Code: 500124

Scrip Code: DRREDDY-EO

Dear Sirs,

Sub: Disclosure of related party transactions for the half year ended September 30, 2020.

Pursuant to Regulation 23(9) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the applicable disclosure on related party transactions for the half year ended September 30, 2020, in the requisite format.

This is for your information and records.

With regards,

,D. ,,./

��,

(

7.1

....

y Secretary

Encl: as above

•••

Dr.Reddy's �;•

Disclosure of Related Party Transactions on Consolidated Basis

  1. In accordance with the provisions of Ind AS 24, Related Party Disclosures and the Companies Act, 2013, Company's Directors, members ofthe Company's Management Council and Company Secretmy are considered as Key Managerial Personnel.

List of Key Managerial Personnel of the Company is as below:

  1. K Satish Reddy G V Prasad Kalpana Morparia

4. Dr. Bruce LA Carter

5.

Sridar Iyengar

Bharat Narotam Doshi

  1. Prasad R Menon
  2. Leo Puri

Shikha Sharma

10. Allan Oberman

  1. Dr. Omkar Goswami (till 30 July 2019)
  1. Anupam Puri (till 26 July 2019)
  2. M V Ramana
  3. Saumen Chakraborty
  4. Ganadhish Kamat
  5. Anil Namboodiripad
  6. Archana Bhaskar
  7. Sanjay Sharma
  8. Sauri Gudlavalleti
  9. P Yugandhar
  10. Erez Israeli
  11. Dr. Raymond de Vre
  12. Deepak Sapra
  13. Marc Kikuchi
  14. Patrick Aghanian (from 7 October 2019)
  15. Sandeep Poddar

Whole-time director (Chairman)

Whole-time director (Co-Chairman and Managing Director) Independent director

Independent director Independent director Independent director Independent director Independent director Independent director Independent director Independent director Independent director Management council member Management council member Management council member Management council member Management council member Management council member Management council member Management council member

CEO and management council member Management council member Management council member Management council member Management council member Company secretary

Dr. Reddy's •·· �;•

b)List ofrelated parties with whom transactions have taken place during the current and/or previous year:

1. K Samrajyam

Mother ofChairman

2.

K Deepti Reddy

Spouse ofChairman

3. G Anuradha

Spouse ofCo-chairman

4.

G Mallika Reddy

Daughter ofCo-chairman

5.

G V Sanjana Reddy

Daughter ofCo-chairman

6. Akhil Ravi

Son-in-lawofCo-chairman

7. Kunshan Rotam Reddy Pharmaceuticals

Enterprise over which the Company exercises joint control with

Company Limited

other joint venture partners and holds 51.33% of equity shares

8.

ORES Energy Private Limited

Enterprise over which the Company exercises joint control with

other joint venture partners and holds 26% of equity shares

9. Dr. Reddy's Institute ofLife Sciences

Enterprise over which whole-time directors have significant

influence

10.Stamlo Industries Limited

Enterprise controlled by whole-time directors

11. Indus Projects Private Limited

Enterprise over which relatives ofwhole-time directors have

significant influence

12.CERG Advisory Private Limited

Enterprise controlled by (erstwhile) Key Managerial Personnel

(till 30 July 2019)

13.AverQ Inc.,USA

Enterprise over which Key Managerial Personnel have significant

influence

14.Shravya Publications Pvt. Ltd.

Enterprise over which whole-time directors and their relatives

have significant influence

15.Cancelled Plans LLP

Enterprise over which relatives ofwhole-time directors have

significant influence

16.Araku Originals Private Limited

Enterprise over which whole-time directors have significant

influence

17.Dr. Reddy's Foundation

Enterprise over which whole-time directors and their relatives

have significant influence

18.Pudami Educational Society

Enterprise over which whole-time directors and their relatives

have significant influence

19.Green Park Hospitality Services Private

Enterprise controlled by relative ofa whole-time director

Limited

20.Green Park Hotels and Resorts Limited

Enterprise controlled by relative ofa whole-time director

Further, the Company contributes to the Dr. Reddy's Laboratories Gratuity Fund, which maintains the plan assets of the Company's Gratuity Plan for the benefit ofits employees.

Dr. Reddy's •·· �;•

c) The following is a summary of significant related party transactions:

Particulars

Research and development services received

Or.Reddy's Institute of Life Sciences

Research and development services provided

Kunshan Rotam Reddy Pharmaceuticals Company Limited

Contributions towards social development

Or.Reddy's Foundation

Pudami Educational Society

Total

Catering services

Green Park Hospitality Services Private Limited

Facility management services paid

Green Park Hospitality Services Private Limited

Hotel expenses

Green Park Hotel and Resorts Limited

Stamlo Industries Limited

Total

Civil works

Indus Projects Private Limited

Sales of goods

Kunshan Rotam Reddy Pharmaceuticals Company Limited

Lease rentals paid to

Key Managerial Personnel

K Satish Reddy

Relatives ofKey Managerial Personnel

Total

Lease rentals received

ORES Energy Private Limited

Purchase of Solar power

ORES Energy Private Limited

Salaries to relatives of Key Managerial Personnel

Other services received

Remuneration to Key Managerial Personnel

Salaries and other benefits<1l

Contributions to defined contribution plans

Commission to directors

Share-based payments expense

Total

All amounts in INR millions

For the half year

For the half year

ended

ended

30-. e -2020

30-Se-2019

52

78

58

108

110

8

8

116

118

139

175

18

3

8

3

4

11

15

48

21

1 I

7

7

12

11

19

18

68

5

4

3

317

320

17

17

170

130

122

79

626

546

•··

Dr.Reddy's �;•

d) The Company has the following amounts due from/ to related parties:

Particulars

Due from related parties

Key Managerial Personnel (towards rent deposits) Green Park Hospitality Services Private Limited ORES Energy Private Limited

Kunshan Rotam Reddy Pharmaceuticals Company Limited

Total

Due to related parties

Indus Projects Private Limited

Green Park Hospitality Services Private Limited

Dr. Reddy's Foundation

Green Park Hotel and Resorts Limited

Stamlo Industries Limited

Total

*Rounded offto millions.

As at 30-Se-2020

8

36

10

54

17

16

16

*

49

As at 30-Se -2019

8

55

19

32

114

15

6

-*-*

21

Disclaimer

Dr. Reddy's Laboratories Limited published this content on 20 November 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 November 2020 10:40:04 UTC


© Publicnow 2020
All news about DR. REDDY'S LABORATORIES LIMITED
01:06pDR REDDY LABORATORIES : Receives Approval to Conduct Phase 3 Clinical Trial of S..
MT
12:34pDR REDDY LABORATORIES : . Reddy's Receives Approval to Conduct Phase 3 Clinical ..
BU
01/12Asian ADRs Move Higher in Tuesday Trading
MT
01/12DR REDDY LABORATORIES : to present at the 39th Annual J.P. Morgan Healthcare Con..
PU
01/12Indian Indices Gain on Tuesday's Closing; Force Motors Rises 3%
MT
01/12DR REDDY LABORATORIES : Gets Nod for Phase-III Clinical Tiral of COVID-19 Vaccin..
MT
01/11DR REDDY LABORATORIES : . Reddy's Says Russia's COVID-19 Vaccine Meets Safety En..
MT
01/11Russia's Sputnik V vaccine found safe in India mid-stage trial -Dr.Reddy's
RE
01/11Asian ADRs Nudge Higher in Monday Trading
MT
01/11DR REDDY LABORATORIES : Sputnik V meets the primary endpoint of safety in the Ph..
BU
More news
Financials
Sales 2021 193 B 2 632 M 2 632 M
Net income 2021 27 774 M 380 M 380 M
Net cash 2021 9 856 M 135 M 135 M
P/E ratio 2021 31,3x
Yield 2021 0,49%
Capitalization 864 B 11 812 M 11 810 M
EV / Sales 2021 4,44x
EV / Sales 2022 3,83x
Nbr of Employees 21 650
Free-Float 68,2%
Chart DR. REDDY'S LABORATORIES LIMITED
Duration : Period :
Dr. Reddy's Laboratories Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DR. REDDY'S LABORATORIES LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 33
Average target price 5 667,23 INR
Last Close Price 5 207,60 INR
Spread / Highest target 22,9%
Spread / Average Target 8,83%
Spread / Lowest Target -23,2%
EPS Revisions
Managers and Directors
NameTitle
Erez Israeli Chief Executive & Operating Officer
Satish Kallam Reddy Co-Chairman
Gunupati Venkateswara Prasad Co-Chairman & Managing Director
Parag Agarwal Chief Financial Officer
Kalpana Jaisingh Morparia Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
DR. REDDY'S LABORATORIES LIMITED0.07%12 050
JOHNSON & JOHNSON2.08%422 918
ROCHE HOLDING AG0.99%301 476
NOVARTIS AG-0.16%214 006
MERCK & CO., INC.0.45%207 893
PFIZER INC.-0.16%204 271